Business Wire
22 Nov 2026, 18:13 UTC · 1h ago
TEVA Investors Have Opportunity to Join Teva Pharmaceutical Industries Limited Fraud Investigation with SBS Law
Impact · against what's priced in
Teva faces potential new legal liabilities following the launch of a fraud investigation by SBS Law. This development introduces uncertainty regarding future litigation reserves and institutional appeal.
- TEVA−0.40
No priced-in read yet
- In context





